Abstract
Get full access to this article
View all access options for this article.
References
1.Deloitte Report . https://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/measuring-return-from-pharmaceutical-innovation.html [Last accessed: March 17, 2023].
2.BMJ Report . http://press.psprings.co.uk/bmj/february/drugprice.pdf [Last accessed: March 17, 2023].
3.
Philippidis
A.
https://liebertgen.wpengine.com/magazine-issues/march-15-2015-vol-35-no-6/despite-big-pharma-retreat-rd-spending-advances-2/ [Last accessed: March 17, 2023].
4.Pharmaceutical Research and Manufacturers of America (PhRMA) . Deductibles and coinsurance drive high out-of-pocket costs for commercially insured patients taking brand medicines. November 14, 2022. https://phrma.org/resource-center/Topics/Access-to-Medicines/Deductibles-and-Coinsurance-Drive-High-Out-Of-Pocket-Costs-for-Commercially-Insured-Patients-Taking-Brand-Medicines [Last accessed: March 17, 2023].